Estrogen Effects on Bone in the Male Skeleton

Luigi Gennari, Sundeep Khosla, John P. Bilezikian

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Studies have started appreciating the fact that the prevalence of osteoporosis in older men is substantial. Estrogen deficiency states such as delayed puberty, amenorrhea of any cause, and, perhaps, the use of progestational agents for contraception, can lead to suboptimal acquisition of peak bone mass. In the male, androgens are thought to be critical to the establishment of peak bone mass. Delayed puberty in otherwise normal boys is associated with reduced bone density for as long as 10 years thereafter compared with boys who entered puberty on time. In sex steroid-sufficient, growing boys and girls, a 7% to 10% difference in the achievement of peak bone mass is believed to be a key protective factor in the male. Thus, not only do men not normally experience an abrupt cessation of androgen production in their middle years, but they also achieve a greater reservoir of bone owing to the attainment of greater peak bone mass in youth. Results from the short-term interventional observations also opened the way to studies on the use of estrogenic compounds in men. Short-term low doses of estradiol have been successfully employed to increase growth velocity in prepubertal boys. Major concerns of either androgen and estrogen treatment in men relate to their possible collateral negative implications in other estrogen targets, such as the gonads, the prostate, and the cardiovascular system. Thus, it is likely that the therapeutic skeletal effects of androgens in men are owing, at least in part, to their conversion to estrogens.

Original languageEnglish (US)
Title of host publicationPrinciples of Bone Biology, Two-Volume Set
PublisherElsevier Inc.
Pages1801-1818
Number of pages18
Volume2
ISBN (Print)9780123738844
DOIs
StatePublished - 2008

Fingerprint

Skeleton
Bone
Estrogens
Bone and Bones
Androgens
Delayed Puberty
Cardiovascular system
Progestins
Estradiol
Steroids
Amenorrhea
Gonads
Therapeutic Uses
Puberty
Cardiovascular System
Contraception
Bone Density
Osteoporosis
Prostate
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Gennari, L., Khosla, S., & Bilezikian, J. P. (2008). Estrogen Effects on Bone in the Male Skeleton. In Principles of Bone Biology, Two-Volume Set (Vol. 2, pp. 1801-1818). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-373884-4.00022-7

Estrogen Effects on Bone in the Male Skeleton. / Gennari, Luigi; Khosla, Sundeep; Bilezikian, John P.

Principles of Bone Biology, Two-Volume Set. Vol. 2 Elsevier Inc., 2008. p. 1801-1818.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gennari, L, Khosla, S & Bilezikian, JP 2008, Estrogen Effects on Bone in the Male Skeleton. in Principles of Bone Biology, Two-Volume Set. vol. 2, Elsevier Inc., pp. 1801-1818. https://doi.org/10.1016/B978-0-12-373884-4.00022-7
Gennari L, Khosla S, Bilezikian JP. Estrogen Effects on Bone in the Male Skeleton. In Principles of Bone Biology, Two-Volume Set. Vol. 2. Elsevier Inc. 2008. p. 1801-1818 https://doi.org/10.1016/B978-0-12-373884-4.00022-7
Gennari, Luigi ; Khosla, Sundeep ; Bilezikian, John P. / Estrogen Effects on Bone in the Male Skeleton. Principles of Bone Biology, Two-Volume Set. Vol. 2 Elsevier Inc., 2008. pp. 1801-1818
@inbook{bc2e1d25d5504cb5a7ecf95cd584d8ad,
title = "Estrogen Effects on Bone in the Male Skeleton",
abstract = "Studies have started appreciating the fact that the prevalence of osteoporosis in older men is substantial. Estrogen deficiency states such as delayed puberty, amenorrhea of any cause, and, perhaps, the use of progestational agents for contraception, can lead to suboptimal acquisition of peak bone mass. In the male, androgens are thought to be critical to the establishment of peak bone mass. Delayed puberty in otherwise normal boys is associated with reduced bone density for as long as 10 years thereafter compared with boys who entered puberty on time. In sex steroid-sufficient, growing boys and girls, a 7{\%} to 10{\%} difference in the achievement of peak bone mass is believed to be a key protective factor in the male. Thus, not only do men not normally experience an abrupt cessation of androgen production in their middle years, but they also achieve a greater reservoir of bone owing to the attainment of greater peak bone mass in youth. Results from the short-term interventional observations also opened the way to studies on the use of estrogenic compounds in men. Short-term low doses of estradiol have been successfully employed to increase growth velocity in prepubertal boys. Major concerns of either androgen and estrogen treatment in men relate to their possible collateral negative implications in other estrogen targets, such as the gonads, the prostate, and the cardiovascular system. Thus, it is likely that the therapeutic skeletal effects of androgens in men are owing, at least in part, to their conversion to estrogens.",
author = "Luigi Gennari and Sundeep Khosla and Bilezikian, {John P.}",
year = "2008",
doi = "10.1016/B978-0-12-373884-4.00022-7",
language = "English (US)",
isbn = "9780123738844",
volume = "2",
pages = "1801--1818",
booktitle = "Principles of Bone Biology, Two-Volume Set",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Estrogen Effects on Bone in the Male Skeleton

AU - Gennari, Luigi

AU - Khosla, Sundeep

AU - Bilezikian, John P.

PY - 2008

Y1 - 2008

N2 - Studies have started appreciating the fact that the prevalence of osteoporosis in older men is substantial. Estrogen deficiency states such as delayed puberty, amenorrhea of any cause, and, perhaps, the use of progestational agents for contraception, can lead to suboptimal acquisition of peak bone mass. In the male, androgens are thought to be critical to the establishment of peak bone mass. Delayed puberty in otherwise normal boys is associated with reduced bone density for as long as 10 years thereafter compared with boys who entered puberty on time. In sex steroid-sufficient, growing boys and girls, a 7% to 10% difference in the achievement of peak bone mass is believed to be a key protective factor in the male. Thus, not only do men not normally experience an abrupt cessation of androgen production in their middle years, but they also achieve a greater reservoir of bone owing to the attainment of greater peak bone mass in youth. Results from the short-term interventional observations also opened the way to studies on the use of estrogenic compounds in men. Short-term low doses of estradiol have been successfully employed to increase growth velocity in prepubertal boys. Major concerns of either androgen and estrogen treatment in men relate to their possible collateral negative implications in other estrogen targets, such as the gonads, the prostate, and the cardiovascular system. Thus, it is likely that the therapeutic skeletal effects of androgens in men are owing, at least in part, to their conversion to estrogens.

AB - Studies have started appreciating the fact that the prevalence of osteoporosis in older men is substantial. Estrogen deficiency states such as delayed puberty, amenorrhea of any cause, and, perhaps, the use of progestational agents for contraception, can lead to suboptimal acquisition of peak bone mass. In the male, androgens are thought to be critical to the establishment of peak bone mass. Delayed puberty in otherwise normal boys is associated with reduced bone density for as long as 10 years thereafter compared with boys who entered puberty on time. In sex steroid-sufficient, growing boys and girls, a 7% to 10% difference in the achievement of peak bone mass is believed to be a key protective factor in the male. Thus, not only do men not normally experience an abrupt cessation of androgen production in their middle years, but they also achieve a greater reservoir of bone owing to the attainment of greater peak bone mass in youth. Results from the short-term interventional observations also opened the way to studies on the use of estrogenic compounds in men. Short-term low doses of estradiol have been successfully employed to increase growth velocity in prepubertal boys. Major concerns of either androgen and estrogen treatment in men relate to their possible collateral negative implications in other estrogen targets, such as the gonads, the prostate, and the cardiovascular system. Thus, it is likely that the therapeutic skeletal effects of androgens in men are owing, at least in part, to their conversion to estrogens.

UR - http://www.scopus.com/inward/record.url?scp=69949087795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949087795&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-373884-4.00022-7

DO - 10.1016/B978-0-12-373884-4.00022-7

M3 - Chapter

AN - SCOPUS:69949087795

SN - 9780123738844

VL - 2

SP - 1801

EP - 1818

BT - Principles of Bone Biology, Two-Volume Set

PB - Elsevier Inc.

ER -